1. Home
  2. MXCT vs WHF Comparison

MXCT vs WHF Comparison

Compare MXCT & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

SELL

Current Price

$1.38

Market Cap

155.8M

Sector

Health Care

ML Signal

SELL

Logo WhiteHorse Finance Inc.

WHF

WhiteHorse Finance Inc.

SELL

Current Price

$7.93

Market Cap

152.5M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
MXCT
WHF
Founded
1999
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
155.8M
152.5M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
MXCT
WHF
Price
$1.38
$7.93
Analyst Decision
Strong Buy
Hold
Analyst Count
6
5
Target Price
$4.11
★ $8.63
AVG Volume (30 Days)
★ 1.4M
102.7K
Earning Date
11-10-2026
11-09-2026
Dividend Yield
N/A
★ 13.21%
EPS Growth
N/A
★ 31.91
EPS
N/A
★ 0.75
Revenue
★ $33,026,000.00
N/A
Revenue This Year
$4.77
N/A
Revenue Next Year
$10.06
$3.16
P/E Ratio
★ N/A
$10.56
Revenue Growth
N/A
★ N/A
52 Week Low
$0.64
$6.07
52 Week High
$1.80
$8.54

Technical Indicators

Market Signals
Indicator
MXCT
WHF
Relative Strength Index (RSI) 55.07 49.21
Support Level $1.02 $7.86
Resistance Level $1.54 $8.54
Average True Range (ATR) 0.14 0.28
MACD -0.01 -0.07
Stochastic Oscillator 70.41 13.99

Price Performance

Historical Comparison
MXCT
WHF

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

About WHF WhiteHorse Finance Inc.

WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.

Share on Social Networks: